Godzilla  jabs: New drug Retatrutide Helps People to lose weight

A new jab( Godzilla) helps people to reduce their weight healthily. The jab is in the trial phase till 2026.

The person in a trial of the drug retatrutide lost up to 29 per cent of their weight in a year.

The study of it suggests Godzilla is more effective than Ozempic, Wegovy and Mounjaro. Retatrutide is unique in that it not only reduces appetite but also increases metabolism, setting it apart from other drugs.

In the study, it was found that women experienced a 28.5% reduction in their body weight, while men only experienced a 21.2% reduction. This suggests that the intervention had a more significant impact on weight loss in women compared to men.

Dr. Ania Jastreboff, director of the Yale Obesity Research Center, presented her striking findings at the European Obesity Congress in Venice.

The drug retatrutide is manufactured by the American pharmaceutical firm Eli Lilly Research Centre.

Nadia Ahmad, Eli Lilly’s Associate Vice President for Obesity, stated, “We’re very excited about the level of weight loss retatrutide has achieved by activating three receptors, which makes it different to those currently on the market.”

If Godzilla jab completes its trial successfully then it will become a miracle for obese people.

1 thought on “Godzilla  jabs: New drug Retatrutide Helps People to lose weight”

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.